Target intelligence / Profile preview

Basophil granulocyte (Basophil)

Target
Basophil
Molecular classification
Other (cell type), Granulocyte, Leukocyte
01

Overview

Basophils are a rare subtype of white blood cell classified as granulocytes. They make up less than 1% of circulating leukocytes but are the largest among the granulocytes. Their primary functions include mediating inflammatory responses—particularly those associated with allergies—and defending against parasites. Basophils contain granules rich in histamine and heparin; upon activation by allergens or pathogens, they release these substances to promote vasodilation and prevent blood clotting. They also secrete cytokines such as IL‑4 that help orchestrate immune responses[1][3][7]. Unlike mast cells—which reside in tissues—basophils circulate in the bloodstream. Abnormal levels may indicate underlying conditions such as chronic myeloid leukemia or other myeloproliferative disorders[4]. While therapies targeting basophils are being explored for allergic and autoimmune diseases, "basophil granulocyte" is not itself a molecular therapeutic target like a receptor or enzyme but rather refers to an entire cell type[6]. **Note:** The entry "Basophil granulocyte" is not a canonical molecular target such as a receptor or enzyme; it refers to an entire cell population rather than a single molecule suitable for direct drug targeting. Therefore, this entry is considered incorrect if used where only molecular targets should be listed.

Other names
Basophilbasophilebasophilic granulocytegranular leukocyte (basophilic type)
02

Biological functions

Immune responseInflammatory responseAllergic reaction mediationParasite defense
03

Disease associations

InflammationAllergy (including anaphylaxis, asthma, atopic dermatitis, hay fever)Infection (especially parasitic)Cancer (notably in some leukemias and myeloproliferative neoplasms)
04

Safety considerations

Overactivation can contribute to severe allergic reactions and anaphylaxis[1][3]
05

Biomarkers

Elevated or decreased basophil count as a marker for allergic disease or certain hematologic malignancies[4][5]

Beyond the preview

Go deeper on Basophil granulocyte (Basophil).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basophil granulocyte (Basophil).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call